Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Curevac N.V.
(NQ:
CVAC
)
2.750
-0.130 (-4.51%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Curevac N.V.
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
CureVac's CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 Congress
September 13, 2024
Via
ACCESSWIRE
GSK Reveals 'Positive' Data From Mid-Stage Study Of Seasonal Influenza mRNA Vaccine
September 12, 2024
GSK announced positive phase 2 trial results for its mRNA seasonal flu vaccine, showing strong immune.
Via
Benzinga
CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress
September 09, 2024
Via
ACCESSWIRE
CVAC Stock Earnings: CureVac Misses EPS, Beats Revenue for Q2 2024
August 20, 2024
CVAC stock results show that CureVac missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
CureVac Names Oncologist and Drug Development Expert Dr. Mehdi Shahidi to Supervisory Board
August 15, 2024
Via
ACCESSWIRE
CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech
July 11, 2024
Via
ACCESSWIRE
GSK and CureVac to Restructure Collaboration into New Licensing Agreement
July 03, 2024
Via
ACCESSWIRE
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update
November 12, 2024
Via
ACCESSWIRE
Insights into CureVac's Upcoming Earnings
November 11, 2024
Via
Benzinga
CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024
November 07, 2024
Via
ACCESSWIRE
CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer
November 04, 2024
Via
ACCESSWIRE
CureVac to Present at the 12th International mRNA Health Conference
November 04, 2024
Via
ACCESSWIRE
CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
October 28, 2024
Via
ACCESSWIRE
CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza mRNA Vaccine Program
September 12, 2024
Via
ACCESSWIRE
CureVac Advances Cancer Vaccine Candidate CVGBM to Part B of Phase 1 Study in Patients with Resected Glioblastoma
August 15, 2024
Via
ACCESSWIRE
CureVac Announces Financial Results for the Second Quarter and First Half of 2024 and Provides Business Update
August 15, 2024
Via
ACCESSWIRE
CVAC Stock Earnings: CureVac Misses EPS, Misses Revenue for Q1 2024
July 12, 2024
CVAC stock results show that CureVac missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Southwest Airlines Adopts a Poison Pill Plan: 7 Things to Know
July 03, 2024
Southwest Airlines is in the news Wednesday after the airline company adopted a poison pill to battle activist investor Elliott Management.
Via
InvestorPlace
Why Is DouYu (DOYU) Stock Up 44% Today?
July 03, 2024
DouYu stock is up on Wednesday after the company announced a special cash dividend for DOYU investors payable in August.
Via
InvestorPlace
CureVac Layoffs 2024: What to Know About the Latest CVAC Job Cuts
July 03, 2024
CureVac layoffs are coming for 30% of the vaccine company's employees as it prepares for a restructuring that will save it over 30% in costs.
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
GOEV Stock: Canoo Receives Fleet Order From Go2 Delivery
July 03, 2024
Canoo stock is down on Wednesday as GOEV investors appear unimpressed by the company's new delivery van fleet deal with Go2 Delivery.
Via
InvestorPlace
DM Stock Alert: Nano Dimension Is Scooping Up Desktop Metal for $183 Million
July 03, 2024
Desktop Metal stock is up on Wednesday as DM investors learn of an acquisition deal with Nano Dimension for the company's shares.
Via
InvestorPlace
CVAC Stock Alert: CureVac Pops on Licensing Deal With GSK
July 03, 2024
CureVac stock is up on Wednesday as CVAC investors react to the company signing a new 1.4 billion euro licensing agreement with GSK.
Via
InvestorPlace
GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
July 03, 2024
GSK and CureVac restructured their collaboration into a new licensing agreement, prioritizing mRNA vaccine development. GSK gains full control of vaccine candidates for influenza and COVID-19, while...
Via
Benzinga
Exposures
COVID-19
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
July 03, 2024
Pre-market stock movers are worth checking out on Wednesday with our breakdown of all the biggest news affecting shares this morning.
Via
InvestorPlace
CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities
July 02, 2024
Via
ACCESSWIRE
CureVac Announces Voting Results of General Meeting
June 24, 2024
Via
ACCESSWIRE
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 18, 2024
Via
Benzinga
First Human Death From Bird Flu Strain Puts Vaccine Stocks Back On The Map
June 06, 2024
Moderna shares are up almost 29% this month; CureVac is up 72% in the past month; and Novavax spiked 317% in the past month.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.